Evaluation of the Efficacy and Safety of VX-864 in Subjects With the PiZZ Genotype
Clinical trial NCT04474197 · COMPLETED
Trial details
- NCT number
- NCT04474197
- Sponsor
- Vertex Pharmaceuticals Incorporated
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-24
- Primary completion
- 2021-05-04
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.